Skip to main navigation
Skip to search
Skip to main content
Sort by
Biochemistry, Genetics and Molecular Biology
P53
100%
Bcl-2
100%
Programmed Cell Death
66%
Stem Cell
50%
Protein Microarray
50%
X-Linked Inhibitory Apoptosis Protein
50%
MicroRNA
50%
Clinical Trial
50%
Nutlin
33%
Clofarabine
33%
CXCR4
33%
Proteomics
16%
Nucleoside Analog
16%
Nucleotide
16%
Hematopoietic Cell
16%
Busulfan
16%
Protein Expression Level
16%
Wild Type
16%
Fludarabine
16%
Small Interfering RNA
16%
R-Factor
16%
Phosphotransferase
16%
Targeted Therapy
16%
Signal Transduction
16%
Precursor
16%
Kinase
16%
Genomics
16%
Phosphoprotein
16%
Cell Cycle Checkpoint
16%
Bcl-2 Family
16%
Kinome
16%
DNA Repair
16%
Keyphrases
Acute Myeloid Leukemia
100%
BH3 Mimetics
35%
B-cell Lymphoma 2 (Bcl-2)
20%
Myeloid Cell leukemia-1 (Mcl-1)
15%
Protein Array
15%
Clinical Trials
15%
Leukemia Stem Cells
10%
MicroRNA Genes
10%
Leukemia Patients
10%
Nucleoside Analogues
10%
Leukemia Cells
10%
Apoptosis
10%
Clofarabine
10%
MDM2 Inhibitor
10%
Nutlin-3
10%
MicroRNA
5%
Non-cytotoxic
5%
Apoptotic Pathway
5%
Reduced Toxicity
5%
Bleeding
5%
Allogeneic Bone Marrow Transplantation
5%
Therapeutic Approaches
5%
Stem Cell Population
5%
Resistance Factor
5%
Combination Chemotherapy
5%
Killer Protein
5%
Apoptotic Cells
5%
Cytotoxic Therapy
5%
Target Response
5%
Targeted Expression
5%
Prognostic Factors
5%
Success Strategies
5%
High-throughput Genomics
5%
P53 Level
5%
Bone Marrow Microenvironment
5%
High-throughput Proteomics
5%
DNA Repair
5%
P53 Pathway
5%
Fludarabine
5%
Bcl-2 Family
5%
Kinase Inhibitor
5%
Precursor Cells
5%
Leukemia Therapy
5%
Highly Integrated
5%
Hematopoietic Stem Cells
5%
Checkpoint Pathway
5%
Small Interfering RNA (siRNA)
5%
Newly Diagnosed
5%
Novel Therapies
5%
Busulfan
5%
Sample Cell
5%
Phosphoprotein
5%
Patient Survival
5%
P53 Target Gene
5%
Mechanistic Studies
5%
Anti-apoptotic Bcl-2
5%
Wild-type p53
5%
Solid Tumor Therapy
5%
Signaling Pathway Proteins
5%
MiR-15a
5%
MiR-16
5%
FMS-like Tyrosine Kinase 3 (FLT3)
5%
Anti-leukemia
5%
Transplant Program
5%
Kinome
5%
Nur77
5%
Molecular Defects
5%
Apoptosis-related Proteins
5%
Protein Expression Level
5%
Ongoing Development
5%
Triterpenoids
5%
Reed
5%
Resistance to Chemotherapy
5%
Protector
5%
Cell Cycle Checkpoint
5%
Preparative Regimen
5%
Patient-specific Treatment
5%
Resistance Mechanism
5%
Major Resistance
5%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
100%
Protein P53
30%
Clinical Trial
15%
microRNA
15%
Leukemia
10%
Clofarabine
10%
Chemotherapy Regimens
10%
Cytotoxic Chemotherapy
5%
R-Factor
5%
Remission
5%
Phosphotransferase
5%
Antiapoptotic
5%
Fludarabine
5%
Infection
5%
Solid Malignant Neoplasm
5%
Neoplasm
5%
Small Interfering RNA
5%
Graft Versus Host Reaction
5%
Triterpenoid
5%
Busulfan
5%
Diseases
5%
Nucleoside Analog
5%
Bardoxolone
5%
Phosphoprotein
5%
Influenza
5%
Pathogenesis
5%